Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...

What is Driving the Growth of the Neurological Disorder Diagnostics Market?The global neurological disorder diagnostics market is experiencing significant growth, driven by the increasing prevalence ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

An enzyme that helps clear damaged mitochondria can act as a molecular switch and potentially prevent neurons from dying.

Over time, the disease can also affect memory and lead to dementia. A similar condition called Lewy Body Dementia (LBD), ...

A Kentucky lawmaker is working to pass a bill that would open up more research on Parkinson’s disease. “Parkinson’s is…it’s a ...

Parkinson’s disease can make regular movements challenging, but staying active can help. “Movement is important,” said Patty ...

Yulan Xiong, associate professor of neuroscience at UConn Health, and her team have discovered one more piece of the puzzle ...

Lancaster University research found that hearing loss may increase the risk of Parkinson’s disease by 57% for every ...

Innovative treatment for Parkinson's disease: microscopic particles combined with light therapy offer a non-surgical solution ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF ...

University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson’s disease patients: uncontrollable movements that develop after years of ...